![](https://s5h9iztgmqa7u6-staging.s3.amazonaws.com/smzs8ahc0kzob6idzw57aixumfq8?response-content-disposition=inline%3B%20filename%3D%22Schizo_Infographic_v2.png%22%3B%20filename%2A%3DUTF-8%27%27Schizo_Infographic_v2.png&response-content-type=image%2Fpng&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAUOWZOASZ5W2ZV4XR%2F20240727%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20240727T031458Z&X-Amz-Expires=259200&X-Amz-SignedHeaders=host&X-Amz-Signature=ed8b66c131c8e11b607de0e1e82834a5636917f6c19faf6578597955f08889bf)
References
*Based on a claims-based analysis of 8985 patients with newly diagnosed and chronic schizophrenia. Individuals had ≥2 claims with a diagnosis code for schizophrenia on separate dates during 2011. The mean cost per patient was compared to the costs in a demographically adjusted nonschizophrenic population.
- McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67-76.
- American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association, 2022.
- World Health Organization. Schizophrenia. Accessed May 26, 2022. https://www.who.int/news-room/fact-sheets/detail/schizophrenia
- Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Ann Rev Clin Psychol. 2014;10:425-438.
- Fitch K, et al. Resource utilization and cost in a commercially insured population with schizophrenia. Am Health Drug Benefits. 2014;7(1):18-26.